Citius Pharmaceuticals, Inc. (CTXR) Earnings
|
Expand Research on CTXR
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -5.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.2% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/25  |
Q325 | N/A | $0.05 | N/A | N/A | $16.06M | N/A | N/A | N/A | ||
| 5/14/25 | Q225 | -$0.11 | $0.00 | -$0.11 | N/A | N/A | N/A |  | | Details | |
| 2/7/25 |
Q125 | N/A | $0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/27/24 |
Q424 | N/A | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/13/24 | Q324 | -$0.06 | -$0.05 | -$0.01 | N/A | N/A | N/A | | | Details | |
| 8/8/24 | Q324 | N/A | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/24 | Q224 | N/A | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/14/24 | Q124 | -$0.06 | N/A | N/A | N/A | $21.3M | N/A | | | Details |
